Latest News for: phase 1 clinical trial
Edit
Killeen Daily Herald
15 Jul 2026
Veradermics to Hold Conference Call to Discuss Study ‘207’ Phase 2 Clinical Trial Results of ...
Conference call will take place on Wednesday, July 15, 2026 at 8.00 am ET ....
Edit
Veradermics to Hold Conference Call to Discuss Study ‘207’ Phase 2 Clinical Trial Results of VDPHL01 in Females with Mild-to-Moderate Pattern Hair Loss (Veradermics Inc)
Public Technologies 15 Jul 2026
VDPHL01 (extended-release minoxidil tablet) is a proprietary investigational, oral non-hormonal drug in Phase 3 development for pattern hair loss in both women and men.
Edit
Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis ...
Nasdaq Globe Newswire 14 Jul 2026
Phase 1 Study Designed to Evaluate the Safety, Tolerability and Pharmacokinetics of AT-587 in Healthy Volunteers ... .
Edit
Hastings Tribune
14 Jul 2026
Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the
Phase 1 Study Designed to Evaluate the Safety, Tolerability and Pharmacokinetics of AT-587 in Healthy Volunteers ... .
Edit
Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus (Atea Pharmaceuticals Inc)
Public Technologies 14 Jul 2026
Edit
Delonix Bioworks Announces First Participant Dosed in Phase 1 Clinical Trial of Next-Generation MenB OMV Vaccine DX-104 in China
PR Newswire 13 Jul 2026
Edit
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant ...
Business Wire 09 Jul 2026
DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver ...
Edit
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer (Delcath Systems Inc)
Public Technologies 09 Jul 2026
... of Oncology (IEO) in Milan, Italy in its global Phase 2 clinical trial evaluating HEPZATO in combination with standard of care (SOC) treatment for liver-dominant metastatic breast cancer (mBC).
Edit
Blue Earth Therapeutics announces first participant dosed in Phase 1 clinical trial investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in metastatic castration-resistant prostate cancer
PR Newswire 09 Jul 2026
... candidate in Blue Earth Therapeutics' oncology pipeline, building on the company's ongoing Lutetium (¹⁷⁷Lu) rhPSMA‑10.1 Injection clinical programme, which is currently in a Phase 2 clinical trial.
Edit
Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of ...
Nasdaq Globe Newswire 07 Jul 2026
Edit
Hengrui Pharma Announces Positive Topline Data from Two Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535 (Jiangsu Hengrui Medicine Co Ltd)
Public Technologies 07 Jul 2026
Edit
92Bio, Inc. Doses First Patient in Phase 1 Clinical Trial of NTB-928 in Platinum-Resistant Ovarian Cancer
Business Wire 02 Jul 2026
Edit
CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Active and Chronic Active Antibody-mediated Rejection (CASI Pharmaceuticals Inc)
Public Technologies 01 Jul 2026
Edit
Theriva™ Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research (ASEBIO - Asociación Española de Bioempresas)
Public Technologies 30 Jun 2026
[...]. This is an abstract of the document. To keep reading, click here and get access to the original version.
- 1
- 2
- Next page »